You are here:

Home
NICE Guidance
Conditions and diseases
Cancer
Blood and bone marrow cancers

Blood and bone marrow cancers Products

A list of all our products on blood and bone marrow cancers

Filter

Product type

Product typeGuidanceQuality standardsAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceDiagnostics guidanceHealthTech guidanceInterventional procedures guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting developmentTopic prioritisation

New and updated

New and updatedNew in the last 6 monthsUpdated in the last 6 months

Showing 2 products

Sort by: Date | Sort by Title

Status: In consultationRemove ‘Status: In consultation’ filter

Histamine dihydrochloride with interleukin-2 for maintenance treatment of acute myeloid leukaemia [ID1627]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
22 May 2026
Expected publication date:
5 August 2026
Daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma when an autologous stem cell transplant is suitable [ID6249]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
4 June 2026
Expected publication date:
6 August 2026